Clinical Trials Arena February 21, 2024
The success of recent trials treating mental health problems with psychedelic therapies has driven a rapid rise in investment.
Psychedelic treatments have been considered in the treatment of mental health since the 1950s, following Albert Hofmann’s development of lysergic acid diethylamide (LSD-25) in 1938. Government intervention and regulation throughout the 1970s slowed potential medical development, but recent success in clinical trials has suggested that mind-altering substances could present an opportunity, particularly within the treatment of mental health conditions including depression, anxiety, post-traumatic stress disorder (PTSD), eating disorders and substance abuse disorders.
Psychedelics treatments: current use and potential
Whilst psychedelics are well established, the use of mind-altering drugs in the treatment of mental health is still in its early days. Development...
Today's Sponsors
Today's Sponsor